Hendrik Falk
Publications by Year
Research Areas
Epigenetics and DNA Methylation, Protein Degradation and Inhibitors, Cancer-related gene regulation, Protein Kinase Regulation and GTPase Signaling, Genomics and Chromatin Dynamics
Most-Cited Works
- → Inhibitors of histone acetyltransferases KAT6A/B induce senescence and arrest tumour growth(2018)305 cited
- → HBO1 is required for the maintenance of leukaemia stem cells(2019)172 cited
- → A RIPK2 inhibitor delays NOD signalling events yet prevents inflammatory cytokine production(2015)148 cited
- → Regulation of PRMT5–MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma(2019)117 cited
- → PAINS: Relevance to Tool Compound Discovery and Fragment-Based Screening(2013)85 cited
- → Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer(2023)62 cited
- → An Efficient High-Throughput Screening Method for MYST Family Acetyltransferases, a New Class of Epigenetic Drug Targets(2011)57 cited
- → Characterization of the Novel Broad-Spectrum Kinase Inhibitor CTx-0294885 As an Affinity Reagent for Mass Spectrometry-Based Kinome Profiling(2013)52 cited
- → Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A(2019)39 cited
- → Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents(2020)27 cited